Evidence map›Paper›PMID 30279584›Full record

ReviewProstate cancer and prostatic diseases2019

Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?

Katelyn A Barnes, Lauren E Ball, Daniel A Galvão, Robert U Newton, Suzanne K Chambers

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Prostate cancer and prostatic diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Katelyn A BarnesMenzies Health Institute Queensland, Griffith University, Gold Coast, Australia. kate.barnes2@griffithuni.edu.au.ORCID http://orcid.org/0000-0001-5891-1331
Lauren E BallMenzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
Daniel A GalvãoExercise Medicine Research Institute, Edith Cowan University, Joondalup, Australia.
Robert U NewtonExercise Medicine Research Institute, Edith Cowan University, Joondalup, Australia.ORCID http://orcid.org/0000-0003-0302-6129
Suzanne K ChambersMenzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
Edith Cowan University · AUGriffith University · AUUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo review the evidence available to support clinical practice guidelines for dietary interventions aimed at mitigating the side effects of androgen deprivation therapy (ADT) in men with prostate cancer, and to identify future research priorities.

methodsAn analytical model was designed to select and interpret evidence for the effect of dietary interventions on ADT side effects. Key terms identified articles that investigated dietary interventions to mitigate ADT side effects among men treated for prostate cancer. Medline, Embase, Proquest, CINAHL, Cochrane databases, and PubMed were searched from inception through June, 2018. Clinical trial registries were also searched for up-to-date study protocols. Articles were not restricted on design. Methodological quality was assessed using the mixed methods appraisal tool.

resultsSixteen articles met inclusion criteria, each with distinct dietary interventions. Twelve studies used interventions that combined diet with physical activity and/or medication and/or counselling. Four articles examined the effect of diet alone on ADT side effects. Of those, three articles measured changes to participants' dietary intake and influence on ADT side effects. One article showed daily caffeinated beverages improved cancer-related fatigue. Two articles showed no impact of isoflavone supplementation on hot flushes, quality of life, body mass index, or blood lipids. Dietary intake and compliance was poorly reported across all studies limiting knowledge of acceptability and feasibility for dietary interventions. Information on the nutrition care practices and views of clinicians treating men for prostate cancer is limited. No articles measured the impact of diet on long-term ADT side effects. Methodological quality of included papers ranged from weak to strong.

conclusionsCurrent evidence for dietary interventions to mitigate ADT side effects is limited. Further investigations are warranted to explore the impact of changes in dietary intake on ADT side effects before practice guidelines can be considered.

Indexed as

Nutrition TherapyAndrogen AntagonistsAntineoplastic Agents, HormonalClinical Trials as TopicCombined Modality TherapyHumansMaleNutrition PolicyPractice Guidelines as TopicProstatic NeoplasmsQuality Assurance, Health CareQuality of LifeTreatment OutcomeAndrogen AntagonistsAntineoplastic Agents, Hormonal

Identifiers

PMID30279584
OpenAlexW2895243901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.